<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rossi F</submitter><funding>NIAID NIH HHS</funding><funding>NHGRI NIH HHS</funding><pagination>1524-31</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4112484</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>370(16)</volume><pubmed_abstract>We report the case of a patient from Brazil with a bloodstream infection caused by a strain of methicillin-resistant Staphylococcus aureus (MRSA) that was susceptible to vancomycin (designated BR-VSSA) but that acquired the vanA gene cluster during antibiotic therapy and became resistant to vancomycin (designated BR-VRSA). Both strains belong to the sequence type (ST) 8 community-associated genetic lineage that carries the staphylococcal chromosomal cassette mec (SCCmec) type IVa and the S. aureus protein A gene (spa) type t292 and are phylogenetically related to MRSA lineage USA300. A conjugative plasmid of 55,706 bp (pBRZ01) carrying the vanA cluster was identified and readily transferred to other staphylococci. The pBRZ01 plasmid harbors DNA sequences that are typical of the plasmid-associated replication genes rep24 or rep21 described in community-associated MRSA strains from Australia (pWBG745). The presence and dissemination of community-associated MRSA containing vanA could become a serious public health concern.</pubmed_abstract><journal>The New England journal of medicine</journal><pubmed_title>Transferable vancomycin resistance in a community-associated MRSA lineage.</pubmed_title><pmcid>PMC4112484</pmcid><funding_grant_id>U54 HG004968</funding_grant_id><funding_grant_id>1U54 HG004968</funding_grant_id><funding_grant_id>R01 AI093749</funding_grant_id><funding_grant_id>U54 HG003079</funding_grant_id><funding_grant_id>K08 AI101005</funding_grant_id><pubmed_authors>Rossi F</pubmed_authors><pubmed_authors>Wollam A</pubmed_authors><pubmed_authors>Tran TT</pubmed_authors><pubmed_authors>Weinstock GM</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Panesso D</pubmed_authors><pubmed_authors>Doi A</pubmed_authors><pubmed_authors>Hernandez-Roldan A</pubmed_authors><pubmed_authors>Narechania A</pubmed_authors><pubmed_authors>Reyes J</pubmed_authors><pubmed_authors>Brandao D</pubmed_authors><pubmed_authors>Rincon S</pubmed_authors><pubmed_authors>Xing G</pubmed_authors><pubmed_authors>Diaz L</pubmed_authors><pubmed_authors>Planet PJ</pubmed_authors><pubmed_authors>Carvajal LP</pubmed_authors><pubmed_authors>Di Gioia TS</pubmed_authors><pubmed_authors>Munita JM</pubmed_authors><pubmed_authors>van der Heijden IM</pubmed_authors><pubmed_authors>Murray BE</pubmed_authors><pubmed_authors>Arias CA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transferable vancomycin resistance in a community-associated MRSA lineage.</name><description>We report the case of a patient from Brazil with a bloodstream infection caused by a strain of methicillin-resistant Staphylococcus aureus (MRSA) that was susceptible to vancomycin (designated BR-VSSA) but that acquired the vanA gene cluster during antibiotic therapy and became resistant to vancomycin (designated BR-VRSA). Both strains belong to the sequence type (ST) 8 community-associated genetic lineage that carries the staphylococcal chromosomal cassette mec (SCCmec) type IVa and the S. aureus protein A gene (spa) type t292 and are phylogenetically related to MRSA lineage USA300. A conjugative plasmid of 55,706 bp (pBRZ01) carrying the vanA cluster was identified and readily transferred to other staphylococci. The pBRZ01 plasmid harbors DNA sequences that are typical of the plasmid-associated replication genes rep24 or rep21 described in community-associated MRSA strains from Australia (pWBG745). The presence and dissemination of community-associated MRSA containing vanA could become a serious public health concern.</description><dates><release>2014-01-01T00:00:00Z</release><publication>2014 Apr</publication><modification>2024-11-11T18:39:01.493Z</modification><creation>2019-03-27T01:32:54Z</creation></dates><accession>S-EPMC4112484</accession><cross_references><pubmed>24738669</pubmed><doi>10.1056/nejmoa1303359</doi><doi>10.1056/NEJMoa1303359</doi></cross_references></HashMap>